Global Serplulimab Injection Market Growth 2026-2032

April 2026 | 77 pages | ID: G21B4086D5CEEN
LP Information

Abstracts

The global Serplulimab Injection market size is predicted to grow from US$ 5.85 million in 2025 to US$ 85.16 million in 2032; it is expected to grow at a CAGR of 47.5% from 2026 to 2032.

Serplulimab (also known as HLX 10) is a recombinant, humanised, anti-PD1 monoclonal antibody, being developed by Shanghai Henlius Biotech.

United States market for Serplulimab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Serplulimab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Serplulimab Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Serplulimab Injection players cover Shanghai Henlius Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Serplulimab Injection Industry Forecast? looks at past sales and reviews total world Serplulimab Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Serplulimab Injection sales for 2026 through 2032. With Serplulimab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serplulimab Injection industry.

This Insight Report provides a comprehensive analysis of the global Serplulimab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Serplulimab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Serplulimab Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serplulimab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serplulimab Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Serplulimab Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100mg/10ml
• Others

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Shanghai Henlius Biotech

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Serplulimab Injection market?
• What factors are driving Serplulimab Injection market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Serplulimab Injection market opportunities vary by end market size?
• How does Serplulimab Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Serplulimab Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Serplulimab Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Serplulimab Injection by Country/Region, 2021, 2025 & 2032
2.2 Serplulimab Injection Segment by Type
  2.2.1 100mg/10ml
  2.2.2 Others
  2.2.3 Serplulimab Injection Sales by Type
    2.2.3.1 Global Serplulimab Injection Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Serplulimab Injection Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Serplulimab Injection Sale Price by Type (2021-2026)
2.3 Serplulimab Injection Segment by Application
  2.3.1 Hospitals
  2.3.2 Clinics
  2.3.3 Others
  2.3.4 Serplulimab Injection Sales by Application
    2.3.4.1 Global Serplulimab Injection Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Serplulimab Injection Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Serplulimab Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Serplulimab Injection Breakdown Data by Company
  3.1.1 Global Serplulimab Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Serplulimab Injection Sales Market Share by Company (2021-2026)
3.2 Global Serplulimab Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Serplulimab Injection Revenue by Company (2021-2026)
  3.2.2 Global Serplulimab Injection Revenue Market Share by Company (2021-2026)
3.3 Global Serplulimab Injection Sale Price by Company
3.4 Key Manufacturers Serplulimab Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Serplulimab Injection Product Location Distribution
  3.4.2 Players Serplulimab Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR SERPLULIMAB INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Serplulimab Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Serplulimab Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Serplulimab Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Serplulimab Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Serplulimab Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Serplulimab Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Serplulimab Injection Sales Growth
4.4 APAC Serplulimab Injection Sales Growth
4.5 Europe Serplulimab Injection Sales Growth
4.6 Middle East & Africa Serplulimab Injection Sales Growth

5 AMERICAS

5.1 Americas Serplulimab Injection Sales by Country
  5.1.1 Americas Serplulimab Injection Sales by Country (2021-2026)
  5.1.2 Americas Serplulimab Injection Revenue by Country (2021-2026)
5.2 Americas Serplulimab Injection Sales by Type (2021-2026)
5.3 Americas Serplulimab Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Serplulimab Injection Sales by Region
  6.1.1 APAC Serplulimab Injection Sales by Region (2021-2026)
  6.1.2 APAC Serplulimab Injection Revenue by Region (2021-2026)
6.2 APAC Serplulimab Injection Sales by Type (2021-2026)
6.3 APAC Serplulimab Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Serplulimab Injection by Country
  7.1.1 Europe Serplulimab Injection Sales by Country (2021-2026)
  7.1.2 Europe Serplulimab Injection Revenue by Country (2021-2026)
7.2 Europe Serplulimab Injection Sales by Type (2021-2026)
7.3 Europe Serplulimab Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Serplulimab Injection by Country
  8.1.1 Middle East & Africa Serplulimab Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Serplulimab Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Serplulimab Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Serplulimab Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Serplulimab Injection
10.3 Manufacturing Process Analysis of Serplulimab Injection
10.4 Industry Chain Structure of Serplulimab Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Serplulimab Injection Distributors
11.3 Serplulimab Injection Customer

12 WORLD FORECAST REVIEW FOR SERPLULIMAB INJECTION BY GEOGRAPHIC REGION

12.1 Global Serplulimab Injection Market Size Forecast by Region
  12.1.1 Global Serplulimab Injection Forecast by Region (2027-2032)
  12.1.2 Global Serplulimab Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Serplulimab Injection Forecast by Type (2027-2032)
12.7 Global Serplulimab Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Shanghai Henlius Biotech
  13.1.1 Shanghai Henlius Biotech Company Information
  13.1.2 Shanghai Henlius Biotech Serplulimab Injection Product Portfolios and Specifications
  13.1.3 Shanghai Henlius Biotech Serplulimab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Shanghai Henlius Biotech Main Business Overview
  13.1.5 Shanghai Henlius Biotech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Serplulimab Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Serplulimab Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100mg/10ml
Table 4. Major Players of Others
Table 5. Global Serplulimab Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Serplulimab Injection Sales Market Share by Type (2021-2026)
Table 7. Global Serplulimab Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Serplulimab Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Serplulimab Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Serplulimab Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Serplulimab Injection Sale Market Share by Application (2021-2026)
Table 12. Global Serplulimab Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Serplulimab Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Serplulimab Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Serplulimab Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Serplulimab Injection Sales Market Share by Company (2021-2026)
Table 17. Global Serplulimab Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Serplulimab Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Serplulimab Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Serplulimab Injection Producing Area Distribution and Sales Area
Table 21. Players Serplulimab Injection Products Offered
Table 22. Serplulimab Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Serplulimab Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Serplulimab Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Serplulimab Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Serplulimab Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Serplulimab Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Serplulimab Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Serplulimab Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Serplulimab Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Serplulimab Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Serplulimab Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Serplulimab Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Serplulimab Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Serplulimab Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Serplulimab Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Serplulimab Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Serplulimab Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Serplulimab Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Serplulimab Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Serplulimab Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Serplulimab Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Serplulimab Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Serplulimab Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Serplulimab Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Serplulimab Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Serplulimab Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Serplulimab Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Serplulimab Injection
Table 52. Key Market Challenges & Risks of Serplulimab Injection
Table 53. Key Industry Trends of Serplulimab Injection
Table 54. Serplulimab Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Serplulimab Injection Distributors List
Table 57. Serplulimab Injection Customer List
Table 58. Global Serplulimab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Serplulimab Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Serplulimab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Serplulimab Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Serplulimab Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Serplulimab Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Serplulimab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Serplulimab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Serplulimab Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Serplulimab Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Serplulimab Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Serplulimab Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Serplulimab Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Serplulimab Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Shanghai Henlius Biotech Basic Information, Serplulimab Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Shanghai Henlius Biotech Serplulimab Injection Product Portfolios and Specifications
Table 74. Shanghai Henlius Biotech Serplulimab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Shanghai Henlius Biotech Main Business
Table 76. Shanghai Henlius Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Serplulimab Injection
Figure 2. Serplulimab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Serplulimab Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Serplulimab Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Serplulimab Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Serplulimab Injection Sales Market Share by Country/Region (2025)
Figure 10. Serplulimab Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100mg/10ml
Figure 12. Product Picture of Others
Figure 13. Global Serplulimab Injection Sales Market Share by Type in 2026
Figure 14. Global Serplulimab Injection Revenue Market Share by Type (2021-2026)
Figure 15. Serplulimab Injection Consumed in Hospitals
Figure 16. Global Serplulimab Injection Market: Hospitals (2021-2026) & (K Units)
Figure 17. Serplulimab Injection Consumed in Clinics
Figure 18. Global Serplulimab Injection Market: Clinics (2021-2026) & (K Units)
Figure 19. Serplulimab Injection Consumed in Others
Figure 20. Global Serplulimab Injection Market: Others (2021-2026) & (K Units)
Figure 21. Global Serplulimab Injection Sale Market Share by Application (2025)
Figure 22. Global Serplulimab Injection Revenue Market Share by Application in 2026
Figure 23. Serplulimab Injection Sales by Company in 2026 (K Units)
Figure 24. Global Serplulimab Injection Sales Market Share by Company in 2026
Figure 25. Serplulimab Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Serplulimab Injection Revenue Market Share by Company in 2026
Figure 27. Global Serplulimab Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Serplulimab Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Serplulimab Injection Sales 2021-2026 (K Units)
Figure 30. Americas Serplulimab Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Serplulimab Injection Sales 2021-2026 (K Units)
Figure 32. APAC Serplulimab Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Serplulimab Injection Sales 2021-2026 (K Units)
Figure 34. Europe Serplulimab Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Serplulimab Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Serplulimab Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Serplulimab Injection Sales Market Share by Country in 2026
Figure 38. Americas Serplulimab Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Serplulimab Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Serplulimab Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Serplulimab Injection Sales Market Share by Region in 2026
Figure 46. APAC Serplulimab Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Serplulimab Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Serplulimab Injection Sales Market Share by Application (2021-2026)
Figure 49. China Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Serplulimab Injection Sales Market Share by Country in 2026
Figure 57. Europe Serplulimab Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Serplulimab Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Serplulimab Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Serplulimab Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Serplulimab Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Serplulimab Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Serplulimab Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Serplulimab Injection in 2026
Figure 74. Manufacturing Process Analysis of Serplulimab Injection
Figure 75. Industry Chain Structure of Serplulimab Injection
Figure 76. Channels of Distribution
Figure 77. Global Serplulimab Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Serplulimab Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Serplulimab Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Serplulimab Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Serplulimab Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Serplulimab Injection Revenue Market Share Forecast by Application (2027-2032)